Department of Neurosurgery, University Hospital Bern, 10 Freiburgstrasse, 3010 Bern, Switzerland.
Stroke. 2012 Dec;43(12):3207-11. doi: 10.1161/STROKEAHA.112.666537. Epub 2012 Oct 30.
Decompressive craniectomy (DC) lowers intracranial pressure and improves outcome in patients with malignant middle cerebral artery stroke. Its usefulness in intracerebral hemorrhage (ICH) is unclear. The aim of this study was to analyze feasibility and safety of DC without clot evacuation in ICH.
We compared consecutive patients (November 2010-January 2012) with supratentorial ICH treated with DC without hematoma evacuation and matched controls treated by best medical treatment. DC measured at least 150 mm and included opening of the dura. We analyzed clinical (age, sex, pathogenesis, Glasgow Coma Scale, National Institutes of Health Stroke Scale), radiological (signs of herniation, side and size of hematoma, midline shift, hematoma expansion, distance to surface), and surgical (time to and indication for surgery) characteristics. Outcome at 6 months was dichotomized into good (modified Rankin Scale 0-4) and poor (modified Rankin Scale 5-6).
Twelve patients (median age 48 years; interquartile range 35-58) with ICH were treated by DC. Median hematoma volume was 61.3 mL (interquartile range 37-83.5 mL) and median preoperative Glasgow Coma Scale was 8 (interquartile range 4.3-10). Four patients showed signs of herniation. Nine patients had good and 3 had poor outcomes. Three patients (25%) of the treatment group died versus 8 of 15 (53%) of the control group. There were 3 manageable complications related to DC.
DC is feasible in patients with ICH. Based on this small cohort, DC may reduce mortality. Larger prospective cohorts are warranted to assess safety and efficacy.
去骨瓣减压术(DC)可降低颅内压并改善恶性大脑中动脉卒中患者的预后。其在脑出血(ICH)中的作用尚不清楚。本研究旨在分析不清除血肿的 DC 在 ICH 中的可行性和安全性。
我们比较了连续的幕上 ICH 患者(2010 年 11 月至 2012 年 1 月)接受不清除血肿的 DC 治疗和接受最佳药物治疗的匹配对照。DC 测量至少 150mm,并包括硬脑膜切开。我们分析了临床(年龄、性别、发病机制、格拉斯哥昏迷量表、美国国立卫生研究院卒中量表)、影像学(脑疝迹象、血肿的侧位和大小、中线移位、血肿扩大、距表面的距离)和手术(手术时间和手术指征)特征。6 个月时的结局分为良好(改良 Rankin 量表 0-4)和不良(改良 Rankin 量表 5-6)。
12 例 ICH 患者接受 DC 治疗(中位年龄 48 岁;四分位间距 35-58)。中位血肿量为 61.3ml(四分位间距 37-83.5ml),术前格拉斯哥昏迷量表中位数为 8(四分位间距 4.3-10)。4 例患者出现脑疝迹象。9 例患者预后良好,3 例患者预后不良。治疗组有 3 例(25%)患者死亡,对照组有 15 例(53%)患者死亡。有 3 例与 DC 相关的可管理并发症。
DC 可应用于 ICH 患者。基于这个小队列,DC 可能降低死亡率。需要更大的前瞻性队列来评估安全性和疗效。